CHRISTUS Health announces new affiliation with Texas A&M Longview, TX, Oct. 07, 2021 (GLOBE NEWSWIRE) -- Texas A&M and CHRISTUS Health today announced a new collaboration to help ensure that Northeast Texas will have access to world-class health...

Sorrento Therapeutics Announces Entry Into Option Agreement to Exclusively License MPRO Inhibitors Against SARS-CoV-2 and Variants of Concern, Including Delta, From Texas A&M University MPro is a SARS-CoV-2 enzyme that catalyzes the formation of a number of essential proteins for the viral reproduction.MPro inhibitors block this catalytic process to potentially inhibit the viral...